DuPont de Nemours, Inc.
DuPont de Nemours, Inc. Q2 FY2025 earnings call
August 5, 2025 · fiscal period ended 2025-06
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2025-08-05
Management highlights
Management Statement and Operational Highlights
- Financial Performance: Second quarter sales totaled $3.3 billion, up 2% organically; operating EBITDA was $859 million, up 8%; adjusted EPS was $1.12, up 15% year-over-year. Full-year earnings guidance is being raised.
- Settlement with New Jersey: DuPont announced a settlement with New Jersey to resolve environmental claims, including PFAS, payable over 25 years with DuPont's portion at $177 million on an NPV basis. AFFF was less than 1% of the total settlement amount.
- Qnity Spin-off: On track for a November 1 separation date. The Qnity Board was composed in June, and a first amendment to the Form 10 registration statement was filed with the SEC in June.
- Investor Day: Scheduled for September 18, focusing on introducing DuPont and Qnity portfolios and their strategies.
- New DuPont Leadership: Assembled a senior leadership team including Jeroen Bloemhard (Healthcare and Water Technologies), Beth Ferreira (Diversified Industrials), and David Cook (Chief Operations and Engineering Officer).
Segment performance
Segment Performance
- ElectronicsCo: Second quarter net sales were $1.2 billion, up 6% year-over-year on both reported and organic bases. Volume increased 8%, offset by a 2% price decrease. Organic sales for semiconductor technologies grew mid-single digits due to strong end market demand from advanced nodes and AI applications, while Interconnect Solutions had high single-digit organic sales growth. Operating EBITDA was $373 million, up 14% year-over-year, with a margin of 31.9%, up 220 basis points from the prior year.
- IndustrialsCo: Second quarter net sales were $2.1 billion, up 1% year-over-year on both reported and organic bases. Volume grew 2%, offset by a 1% price decrease. Healthcare & Water sales were up high single digits organically, while Diversified Industrial sales were down low single digits organically due to construction market softness. Operating EBITDA was $509 million, up 3% year-over-year, with a margin of 24.4%, up 50 basis points from the prior year.
Guidance
Guidance
- Full-year total company net sales midpoint remains unchanged at $12.85 billion. The full-year operating EBITDA midpoint is raised to $3.36 billion, and adjusted EPS midpoint is raised to $4.40 per share.
- Third quarter net sales are estimated at $3.32 billion, operating EBITDA at $875 million, and adjusted EPS at $1.15 per share, including a $0.02 tariff headwind and a $0.05 year-over-year tax headwind. The third quarter assumes about 3% organic sales growth led by healthcare, water, and electronics end markets, partially offset by construction weakness.
Risks
Risks
- Tariff Impact: Net tariff impact in the second half of 2025 is estimated as a $20 million headwind or $0.04 per share, equally split between the third and fourth quarters.
- Environmental Claims: Potential future environmental claims related to PFAS and AFFF, with settlements structured over extended periods.
Q&A highlights
Question and Answer
Q: Drill in on IndustrialsCo price decline A: Related to price adjustments from the inflationary period, looking to reduce the headwind by lapsing concessions from 2024.
Q: Settlement and AFFF A: Settlement paid over 25 years, AFFF portion in line with expected range, North Carolina site to be addressed with similar structured settlements.
Q: Healthcare & Water growth A: Both businesses up nicely, recovering from destock, driven by megatrends and strong customer relationships.
Q: Electronics trends A: Mixed environment, AI-driven applications driving growth, well positioned in advanced nodes and semiconductor packaging.
Q: Healthcare & Water drivers A: Megatrends, strong customer relationships, market position, and China share regain after destock.
Q: Interconnect Solutions growth slowdown A: Year-over-year comp, recovery starting, momentum to continue into the back half of the year.
Q: PFAS agreement EBITDA A: Minimum EBITDA reset at separation, providing a cushion for future divestments.
Q: Aramids divestment A: No comment, focus on Qnity separation by November 1.
Q: Chinese Tyvek investigation A: Dismissed, suspended, happy with the conclusion as it was related solely to Tyvek.
Q: Tariff impact $20 million A: Based on a 90-day pause in tariffs, watching changes, with over 90% of the headwind mitigated by supply chain movements.
Q: Water business core to New DuPont A: Yes, considered core, with plans to grow and invest in the Healthcare & Water portfolio driven by megatrends.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
August 5, 2025Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.